The genome regulators in cancer: a review for urologists
Vlachiotis, I.; Gialas, I.; Tsintavis, A.
Journal of BUON Official Journal of the Balkan Union of Oncology 8(3): 217-220
2003
ISSN/ISBN: 1107-0625 PMID: 17472254 Document Number: 558193
Document emailed within 1 workday
Related Documents
Burnouf, D.; Miturski, R.; Nagao, M.; Nakagama, H.; Nothisen, M.; Wagner, J.; Fuchs, R.P. 2000: Molecular approach in cancer epidemiology: early detection of carcinogen-induced mutations in a whole genome (Review) International Journal of Molecular Medicine 5(1): 15-20Zhang, X.Q.; Yang, C.Y.; Rao, X.F.; Xiong, J.P. 2016: Plumbagin shows anti-cancer activity in human breast cancer cells by the upregulation of p53 and p21 and suppression of G1 cell cycle regulators European Journal of Gynaecological Oncology 37(1): 30-35
Colombel, M.; Davin, J.-L.; Filleul, A.; Rousseau, C. 2004: Diagnosis and management of advanced hormone-refractory prostate cancer: results of a practice survey on 301 French urologists Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 14(2): 182-188
Costa, A.; Nappi, R.E.; Smeraldi, A.; Bergamaschi, M.; Navarra, P.; Grossman, A. 2001: Novel regulators of the in vitro release of hypothalamic corticotrophin-releasing hormone two decades after its discovery: a review Functional Neurology 16(4 Suppl): 205-216
Tutton, P.J.; Barkla, D.H. 1987: Biogenic amines as regulators of the proliferative activity of normal and neoplastic intestinal epithelial cells (review) Anticancer Research 7(1): 1-12
De Almagro, M.C.; Vucic, D. 2012: The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy Experimental Oncology 34(3): 200-211
Nakazawa, T. 2000: Genome analysis of pathogenic bacteria--a review Nihon Rinsho. Japanese Journal of Clinical Medicine 58(6): 1315-1325
Zhdanov, V.M.; Terent'ev, V.F.; Fateeva, A.P.; Kitaeva, L.K.; Gaĭdamovich, S.I. 1977: Integration of virus genome with the genome of brain cells during tick-borne encephalitis with a progressive course Vestnik Akademii Meditsinskikh Nauk SSSR 7: 13-15
Nielsen, F.C.; Lassen, U. 2014: The genome and cancer treatment Ugeskrift for Laeger 176(46)
Waye, J.S. 1989: Discussion of "Repetitive Deoxyribonucleic Acid (DNA) and Human Genome Variation--A Concise Review Relevant to Forensic Biology" Journal of Forensic Sciences 34(6): 1296-1301
Quenu, L. 1975: Neurologic diagnoses by urologists Acta Urologica Belgica 43(1): 107-109
Lowen, J.T. 2010: Women urologists. Trailblazers Minnesota Medicine 93(8): 8-10
Kashiwagi, H.; Uchida, K. 2000: Genome-wide profiling of gene amplification and deletion in cancer Human Cell 13(3): 135-141
Paces, V. 1975: Beginings of cooperation between the urologists and radiologists Ceskoslovenska Radiologie 29(5): 356-357
Robson, R. 1995: Professional liability problems for urologists Canadian Journal of Urology 2(Supp 1): 18-22
Jin, G.; Shen, H. 2015: Cancer risk prediction in post-genome-wide association study era Zhonghua Liu Xing Bing Xue Za Zhi 36(10): 1045-1046
Tanaka, H. 2015: Genome-cohort studies for the development of personalized cancer prevention programs in Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(5): 544-547
Mouraviev, V.; Gleave, M.E.; Forssmann, W.; Huggins, C.B. 2003: A meaningful legacy: urologists as Nobel Prize laureates Canadian journal of urology 10(1): 1737-1742
Talseth, T.; Hedlund, H. 1997: Benign prostatic hyperplasia. Shared care between urologists and general practitioners Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 117(3): 389-393
Kunkel, M.J.; Iannini, P.B.; Landes, R.; Harrison, L.; Wells, G.; Snow, R.; Schaeffer, A.J.; Goldstein, E.J.; Berman, S. 1990: Norfloxacin use in urinary tract infection by urologists and infectious disease specialists European Urology 17(Suppl): 30-33